BASSI, Claudio
 Distribuzione geografica
Continente #
EU - Europa 43.760
NA - Nord America 39.193
AS - Asia 25.115
SA - Sud America 3.287
Continente sconosciuto - Info sul continente non disponibili 898
AF - Africa 616
OC - Oceania 100
AN - Antartide 2
Totale 112.971
Nazione #
US - Stati Uniti d'America 38.370
RU - Federazione Russa 12.492
IT - Italia 10.609
SG - Singapore 10.093
GB - Regno Unito 9.040
CN - Cina 7.765
BR - Brasile 2.606
DE - Germania 2.282
HK - Hong Kong 2.089
FR - Francia 2.037
SE - Svezia 1.991
VN - Vietnam 1.942
IE - Irlanda 1.664
FI - Finlandia 1.422
KR - Corea 778
UA - Ucraina 544
NL - Olanda 462
BD - Bangladesh 437
CA - Canada 425
IN - India 378
JP - Giappone 327
TR - Turchia 276
AR - Argentina 248
MX - Messico 224
ES - Italia 191
PL - Polonia 182
ID - Indonesia 162
ZA - Sudafrica 141
IQ - Iraq 139
BE - Belgio 136
NG - Nigeria 134
AT - Austria 129
CZ - Repubblica Ceca 106
EC - Ecuador 102
PK - Pakistan 99
AU - Australia 83
CH - Svizzera 81
UZ - Uzbekistan 80
CO - Colombia 79
SA - Arabia Saudita 78
VE - Venezuela 75
LT - Lituania 59
MA - Marocco 55
CL - Cile 52
IR - Iran 49
TG - Togo 48
TN - Tunisia 48
PY - Paraguay 45
PH - Filippine 43
RO - Romania 41
AE - Emirati Arabi Uniti 38
IL - Israele 36
JO - Giordania 36
PE - Perù 36
EG - Egitto 33
BJ - Benin 32
JM - Giamaica 32
KE - Kenya 31
AL - Albania 29
AZ - Azerbaigian 29
MY - Malesia 28
NP - Nepal 28
CR - Costa Rica 26
BG - Bulgaria 25
KZ - Kazakistan 24
DZ - Algeria 23
PT - Portogallo 23
OM - Oman 22
TH - Thailandia 22
GR - Grecia 21
HN - Honduras 21
EU - Europa 20
HR - Croazia 20
HU - Ungheria 20
RS - Serbia 20
UY - Uruguay 20
LV - Lettonia 19
KG - Kirghizistan 18
BO - Bolivia 16
BY - Bielorussia 15
LU - Lussemburgo 14
PA - Panama 14
SI - Slovenia 14
TT - Trinidad e Tobago 14
ET - Etiopia 13
LB - Libano 13
AM - Armenia 12
GT - Guatemala 12
DK - Danimarca 11
NO - Norvegia 11
NZ - Nuova Zelanda 11
NI - Nicaragua 10
PR - Porto Rico 10
DO - Repubblica Dominicana 9
MD - Moldavia 9
QA - Qatar 8
SY - Repubblica araba siriana 8
BA - Bosnia-Erzegovina 7
GA - Gabon 7
KW - Kuwait 7
Totale 111.915
Città #
Southend 7.927
Singapore 5.433
Moscow 4.234
Chandler 4.013
Ashburn 4.007
San Jose 3.365
Jacksonville 3.208
Dallas 2.857
Woodbridge 2.349
Hong Kong 2.052
Dublin 1.633
Ann Arbor 1.552
Verona 1.529
The Dalles 1.295
Council Bluffs 1.283
Beijing 1.243
Houston 1.179
Milan 812
New York 786
Rome 675
Ho Chi Minh City 642
Lawrence 637
Munich 636
Princeton 636
Los Angeles 632
Wilmington 631
Jinan 583
Nanjing 535
Shenyang 444
Hanoi 428
Helsinki 415
Santa Clara 354
Buffalo 324
Hebei 307
Sindelfingen 305
Tianjin 292
Tokyo 284
São Paulo 275
Redondo Beach 238
Zhengzhou 221
Columbus 209
Haikou 202
Ningbo 197
Orem 188
Hangzhou 180
Redmond 175
Changsha 172
Seattle 172
Bologna 171
Boardman 169
Turku 162
Nanchang 158
Guangzhou 157
Lancaster 149
Montreal 145
Taiyuan 140
London 138
Naples 138
Florence 133
Brussels 130
Warsaw 130
Jiaxing 126
Taizhou 124
Frankfurt am Main 122
Brooklyn 119
Turin 119
Abuja 118
Toronto 113
Chennai 112
Denver 109
Chicago 108
Atlanta 104
San Francisco 104
Stockholm 103
Fairfield 97
Amsterdam 96
Falls Church 96
Norwalk 92
Johannesburg 91
Da Nang 90
Nuremberg 90
Phoenix 89
Catania 88
Rio de Janeiro 86
Genoa 81
Lanzhou 81
Haiphong 78
Seoul 77
Jakarta 75
Belo Horizonte 73
Redwood City 73
Washington 72
Bari 71
Falkenstein 71
Fuzhou 70
Vienna 70
Tashkent 68
Manchester 67
Mexico City 62
Poplar 61
Totale 67.212
Nome #
L’infiltrazione vascolare della vena porta e/o mesenterica superiore è ancora segno di non resecabilità chirurgica nelle neoplasie del pancreas ? 7.654
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA) 308
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 293
Resezione intermedia e pancreasectomia distale per neoplasie benigne del pancreas: confronto per complicanze postoperatorie e costi 287
Whole-genome landscape of pancreatic neuroendocrine tumours 287
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 270
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature 262
7T MRI and histology reveal early tissue and perfusion changes after radiofrequency ablation in a murine colorectal cancer model 260
Genomic analyses identify molecular subtypes of pancreatic cancer 258
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 256
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 255
Influenza del sito d’ infezione (pancreas) sulla farmacocinetica e farmacodinamica di piperacillina-tazobactam 254
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 253
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 252
Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. 251
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 249
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 248
[Bilemia: diagnosis and conservative treatment. Apropos of a case complicated by hepatic abscess]. 248
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 247
Gα15 in early onset of pancreatic ductal adenocarcinoma 244
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 243
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 243
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms 242
Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction 241
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 240
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 238
[Closed surgical treatment in acute severe pancreatitis] 237
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 235
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 235
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. 234
A root-cause analysis of mortality following major pancreatectomy 232
Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. 231
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. 230
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 229
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 227
Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study 224
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 222
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 222
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 222
Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS) 222
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 221
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 221
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 221
Progetto integrato per la ricerca traslazionale nel carcinoma duttale del pancreas [Integrated project for the translational research on pancreatic ductal carcinoma] 220
Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study 220
Antibiotics penetration in human necrotizing pancreatitis (NP). 219
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer 219
[Cystic tumors of the pancreas: diagnosis, management and results] 219
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 219
Piperacillin-Tazobactam penetration into human pancreatic juice 218
Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival. 218
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models 217
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 217
Adenocarcinoma pancreatico umano primario ed espressione dell’ossido nitrico sintetasi inducibile e cicloossigenasi–2. 216
SEL1L expression in pancreatic adenocarcinoma parallels SMAD4 expression and tumor growth in vito and in vivo. 216
UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AS A NEW USEFUL MARKER IN PANCREATIC CANCER: PRELIMINARY RESULTS 216
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 216
[A case of suppurated urachal cyst (clinical study)]. 215
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma 215
RON is not a prognostic marker for resectable pancreatic cancer 215
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 214
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 214
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 213
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Results of a prospective protocol on the management of 109 consecutive patients. 212
Clinical and Morphological Features of Paraduodenal Pancreatitis: An Italian Experience With 120 Patients 212
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 212
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 211
Triple approach strategy for patients with locally advanced pancreatic carcinoma 211
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 211
Cystic tumors of the pancreas. Pathology 210
Farmacocinetica e farmacodinamica di piperacillina–tazobactam in pazienti con fistola pancreatica esterna 209
Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy 208
Delaying surgery for patients with a previous SARS-CoV-2 infection 208
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 208
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer 208
Caso clinico: il diverticolo duodenale interno 207
Acute pancreatitis at the beginning of the 21st century: the state of the art. 207
Use of Operative Sonography In Carcinoma of the Pancreas 207
Sex differences in oncogenic mutational processes 207
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 206
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study 206
Effect of alcohol and smoking on pancreatic lithogenesis in the course of chronic pancreatitis. 205
Laparoscopic distal pancreatectomy: results on a consecutive series of 58 patients. 204
Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis 203
Alcohol, smoking and papillomavirus infection as risk factors for esophageal squamous-cell papilloma and esophageal squamous-cell carcinoma in Italy. 203
Lactobacillus planctarum reduces infection of pancreatic necrosis in experimetal acute pancreatitis. 202
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 202
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 202
Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. 201
Preliminary Microbiological and Antibiotic Kinetic-study On Prevention and Treatment of Pancreatic Infections 201
Methylation Dynamics of RASSF1A and Its Impact on Cancer 200
Clinical Strategy In Severe Hemorrhage Due To Pancreatic Pseudocysts 198
A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma. 197
Autoimmune pancreatitis: possibilities of CT characterization. 197
Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers 197
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 197
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 197
IAP/APA evidence-based guidelines for the management of acute pancreatitis 197
Non-functioning Islet Cell Tumors - A Consideration of 8 Cases 196
Pancreatic Hepatoid Carcinoma: A Review of the Literature 196
Totale 29.839
Categoria #
all - tutte 366.435
article - articoli 333.761
book - libri 1.278
conference - conferenze 17.475
curatela - curatele 0
other - altro 4.934
patent - brevetti 947
selected - selezionate 0
volume - volumi 8.040
Totale 732.870


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.984 0 1.253 128 358 256 276 140 322 264 154 527 1.306
2022/202312.530 847 1.204 1.134 2.015 1.018 2.790 294 978 1.345 200 398 307
2023/20246.742 371 619 612 817 719 849 410 515 121 326 918 465
2024/202515.831 1.013 1.002 585 2.465 942 581 972 913 2.192 998 1.374 2.794
2025/202642.737 3.090 2.069 3.084 6.664 10.435 3.098 4.064 2.382 3.575 2.390 878 1.008
2026/20271.826 592 1.234 0 0 0 0 0 0 0 0 0 0
Totale 112.971